Cerebral protection: Inflammation, endothelial dysfunction, and postoperative cognitive dysfunction

Current Opinion in Anaesthesiology

Volumn 27, Issue 1, 2014, Pages 89-97

  Riedel, Bernhard ^a   Browne, Kimberley ^a   Silbert, Brendan ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

endothelial dysfunction; neuro inflammation; postoperative cognitive dysfunction

Indexed keywords

BIOLOGICAL MARKER;

ANESTHESIST; BLOOD BRAIN BARRIER; BRAIN MALARIA; CELL MIGRATION; ENDOTHELIAL DYSFUNCTION; GENOMICS; HUMAN; MACROPHAGE; MOLECULAR MECHANICS; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COGNITIVE DYSFUNCTION; PRIORITY JOURNAL; REVIEW; SYNAPSE; TRANSLATIONAL RESEARCH;

ANTI-INFLAMMATORY AGENTS; BLOOD-AQUEOUS BARRIER; COGNITION DISORDERS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 84891836254     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000032     Document Type: Review

References (60)

1. Silbert B, Evered L, Scott DA. Cognitive decline in the elderly: is anaesthesia implicated? Best Pract Res Clin Anaesthesiol 2011; 25:379-393.
2. Evered L, Scott DA, Silbert B, Maruff P. Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg 2011; 112: 1179-1185.
3. van Dijk D, Jansen EW, Hijman R, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA 2002; 287:1405-1412.
4. Marasco SF, Sharwood LN, Abramson MJ. No improvement in neurocognitive outcomes after off-pump versus on-pump coronary revascularisation: a metaanalysis. Eur J Cardiothorac Surg 2008; 33:961-970.
5. Hogue CW Jr, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg 2006; 103:21-37.
6. Liu YH, Wang DX, Li LH, et al. The effects of cardiopulmonary bypass on the number of cerebral microemboli and the incidence of cognitive dysfunction after coronary artery bypass graft surgery. Anesth Analg 2009; 109:1013-1022.
7. Van Dijk D, Kalkman CJ. Why are cerebral microemboli not associated with cognitive decline? Anesth Analg 2009; 109:1006-1008.
8. Cibelli M, Fidalgo AR, Terrando N, et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol 2010; 68:360-368.
9. Eckenhoff RG, Laudansky KF. Anesthesia, surgery, illness and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2012; 47:162-166.
10. Terrando N, Eriksson LI, Ryu JK, et al. Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol 2011; 70:986-995.
11. Terrando N, Monaco C, Ma D, et al. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci USA 2010; 107:20518-20522.
12. Cunningham C, Wilcockson DC, Campion S, et al. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 2005; 25:9275-9284.
13. Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 2007; 7:161-167.
14. Cunningham C, Campion S, Teeling J, et al. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded rna (poly i:C). Brain Behav Immun 2007; 21:490-502.
15. Qin L, WuX, Block ML, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007; 55:453-462.
16. Sly LM, Krzesicki RF, Brashler JR, et al. Endogenous brain cytokine mrna and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of alzheimer's disease. Brain Res Bull 2001; 56:581-588.
17. Kitazawa M, Oddo S, Yamasaki TR, et al. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of alzheimer's disease. J Neurosci 2005; 25:8843-8853.
18. Bajaj JS, Ridlon JM, Hylemon PB, et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 2012; 302:G168-G175.
19. Audet MC, Anisman H. Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses. Front Cell Neurosci 2013; 7:68.
20. Kohl BA, Deutschman CS. The inflammatory response to surgery and trauma. Curr Opin Crit Care 2006; 12:325-332.
21. Oka Y, Murata A, Nishijima J, et al. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992; 4:298-304.
22. Baigrie RJ, Lamont PM, Kwiatkowski D, et al. Systemic cytokine response after major surgery. Br J Surg 1992; 79:757-760.
23. Parolari A, Camera M, Alamanni F, et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg 2007; 84:823-828.
24. Hall GM, Peerbhoy D, Shenkin A, et al. Hip and knee arthroplasty: a comparison and the endocrine, metabolic and inflammatory responses. Clin Sci 2000; 98:71-79.
25. Hogevold HE, Lyberg T, Kahler H, et al. Changes in plasma IL-1beta, TNFalpha and IL-6 after total hip replacement surgery in general or regional anaesthesia. Cytokine 2000; 12:1156-1159.
26. Li X, Robertson CM, Yu X, et al. Early postoperative systemic inflammatory response is an important determinant for adverse 2-year neurodevelopmentassociated outcomes after the norwood procedure. J Thorac Cardiovasc Surg 2013. [Epub ahead of print]. doi: 10.1016/j.jtcvs.2013.07.079.
27. Riedel B, Rafat N, Browne K, et al. Perioperative implications of vascular endothelial dysfunction: current understanding of this critical sensor-effector organ. Curr Anesthesiol Rep 2013. [Epub ahead of print]. doi: 10.1007/s40140-40013-40024-40147.
28. Cepinskas G, Wilson JX. Inflammatory response in microvascular endothelium in sepsis: role of oxidants. J Clin Biochem Nutr 2008; 42:175-184.
29. Avogaro A, Albiero M, Menegazzo L, et al. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 2011; 34 (Suppl. 2): S285-S290.
30. Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002; 105:1567-1572.
31. Schier R, Hinkelbein J, Marcus H, et al. Preoperative microvascular dysfunction: a prospective, observational study expanding risk assessment strategies in major thoracic surgery. Ann Thorac Surg 2012; 94:226-233.
32. Bhagat K, Moss R, Collier J, Vallance P. Endothelial 'stunning' following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res 1996; 32:822-829.
33. Hughes CG, Morandi A, Girard TD, et al. Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology 2013; 118:631-639.
34. Davis JS, Yeo TW, Thomas JH, et al. Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care 2009; 13:R155.
35. Itzhaki S, Lavie L, Pillar G, et al. Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep 2005; 28:594-600.
36. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368:1279-1290.
37. Hu YJ, Wei AN, Chook P, et al. Impact of noncardiovascular surgery on reactive hyperaemia and arterial endothelial function. Clin Exp Pharmacol Physiol 2013; 40:466-472.
38. Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.
39. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by noninvasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010; 31:1142-1148.
40. Bonetti PO, Pumper GM, Higano ST, et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004; 44:2137-2141.
41. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008; 117:2467-2474.
42. Wright CI, Scholten HJ, Schilder JC, et al. Arterial stiffness, endothelial function and microcirculatory reactivity in healthy young males. Clin Physiol Funct Imaging 2008; 28:299-306.
43. Hu Y, Liang D, Li X, et al. The role of interleukin-1 in wound biology. Part I. Murine in silico and in vitro experimental analysis. Anesth Analg 2010; 111:1525-1533.
44. Hildebrandt U, Kessler K, Plusczyk T, et al. Comparison of surgical stress between laparoscopic and open colonic resections. Surg Endosc 2003; 17:242-246.
45. Kugisaki H, Sonohata M, Komine M, et al. Serum concentrations of interleukin-6 in patients following unilateral versus bilateral total knee arthroplasty. J Orthopaed Sci 2009; 14:437-442.
46. Hudetz JA, Gandhi SD, Iqbal Z, et al. Elevated postoperative inflammatory biomarkers are associated with short-and medium-term cognitive dysfunction after coronary artery surgery. J Anesth 2011; 25:1-9.
47. Akiyama H, Barger S, Barnum S, et al. Inflammation and alzheimer's disease. Neurobiol Aging 2000; 21:383-421.
48. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group. Forbes JF, Cuzick J, Buzdar A, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 2008; 9:45-53.
49. Demicheli R, Biganzoli E, Boracchi P, et al. Recurrence dynamics does not depend on the recurrence site. Breast Cancer Res 2008; 10:R83.
50. Forget P, Vandenhende J, Berliere M, et al. Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg 2010; 110:1630-1635.
51. Retsky M. New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms. Int J Environ Res Public Health 2009; 6:329-348.
52. Karnezis T, Shayan R, Caesar C, et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 2012; 21:181-195.
53. Iinuma H, Watanabe T, Mimori K, et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 2011; 29:1547-1555.
54. Hofer SO, Shrayer D, Reichner JS, et al. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg 1998; 133:383-389.
55. Bogden AE, Moreau JP, Eden PA. Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 1997; 75:1021-1027.
56. Noblett SE, Snowden CP, Shenton BK, Horgan AF. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg 2006; 93:1069-1076.
57. Hindler K, Shaw AD, Samuels J, et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105: 1260-1272.
58. Vacas S, Degos V, Tracey KJ, Maze M. High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages. Anesthesiology 2013. [Epub ahead of print]
59. Terrando N, Gomez-Galan M, Yang T, et al. Aspirin-triggered resolvin d1 prevents surgery-induced cognitive decline. FASEB J 2013; 27:3564-3571.
60. Nacer A, Movila A, Baer K, et al. Neuroimmunological blood brain barrier opening in experimental cerebral malaria. PLoS Pathog 2012; 8:e1002982.